Growth Metrics

Ultragenyx Pharmaceutical (RARE) Share-based Compensation Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -25.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -25.00%
Dec 31, 2025 -6.65%
Sep 30, 2025 -10.97%
Jun 30, 2025 -1.90%
Mar 31, 2025 -99.89%
Dec 31, 2024 19.74%
Sep 30, 2024 19.19%
Jun 30, 2024 13.59%
Mar 31, 2024 15.57%
Dec 31, 2023 14.18%
Sep 30, 2023 -2.47%
Jun 30, 2023 -3.38%
Mar 31, 2023 8.73%
Dec 31, 2022 9.46%
Sep 30, 2022 32.50%
Jun 30, 2022 32.14%
Mar 31, 2022 20.94%
Dec 31, 2021 17.43%
Sep 30, 2021 32.69%
Jun 30, 2021 21.12%
Mar 31, 2021 20.56%
Dec 31, 2020 16.16%
Sep 30, 2020 2.18%
Jun 30, 2020 0.91%
Mar 31, 2020 -0.33%
Dec 31, 2019 -6.74%
Sep 30, 2019 -3.68%
Jun 30, 2019 13.52%
Mar 31, 2019 7.58%
Dec 31, 2018 7.88%
Sep 30, 2018 20.30%
Jun 30, 2018 16.49%
Mar 31, 2018 29.64%
Dec 31, 2017 44.34%
Sep 30, 2017 25.46%
Jun 30, 2017 54.64%
Mar 31, 2017 41.91%
Dec 31, 2016 42.67%
Sep 30, 2016 73.43%
Jun 30, 2016 113.32%
Mar 31, 2016 324.29%
Dec 31, 2015 374.21%
Sep 30, 2015 377.97%
Jun 30, 2015 438.16%
Mar 31, 2015 202.89%
Dec 31, 2014 852.86%
Sep 30, 2014 2,226.76%
Jun 30, 2014 411.35%
Mar 31, 2014 316.23%